Biofrontera
BFRI
13 hedge funds and large institutions have $2.39M invested in Biofrontera in 2025 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 2 closing their positions.
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
64% more capital invested
Capital invested by funds: $1.45M → $2.39M (+$935K)
30% more funds holding
Funds holding: 10 → 13 (+3)
2.29% more ownership
Funds ownership: 21.62% → 23.91% (+2.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
+$149K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$103K |
| 3 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$64.8K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$18.8K |
| 5 |
Renaissance Technologies
New York
|
+$16.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$15K |
| 2 |
HF
HRT Financial
New York
|
-$8K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$12 |
| 4 |
SS
SBI Securities
Tokyo,
Japan
|
-$1 |
BFRI Hedge Fund Activity: Q3 2025 in Review
13 of the 7,640 institutional investors tracked by Wall St. Rank reported a position in Biofrontera (BFRI) for Q3 2025, worth a combined $2.39M — up 64% from $1.45M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new BFRI positions and 2 closed out — a net gain of 3 holders — while 5 added to existing stakes and 2 trimmed.
The largest buyer was Rosalind Advisors, adding an estimated $149K. The largest seller was Virtu Financial, exiting entirely with an estimated $15K sold.
- 13 institutional investors held Biofrontera (BFRI) as of Q3 2025, up from 10 in Q2 2025.
- Funds reported $2.39M of Biofrontera stock for Q3 2025, up 64% quarter-over-quarter.
- 5 funds opened new Biofrontera positions in Q3 2025 and 2 closed out, a net change of +3 holders.
- The largest Biofrontera buyer in Q3 2025 was Rosalind Advisors, an estimated $149K added.
- The largest Biofrontera seller in Q3 2025 was Virtu Financial, an estimated $15K sold.
Based on aggregated 13F filings for Q3 2025.